- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metabolism; Disorder, Postprocedural in United Kingdom
Total 67671 results
-
University of Central LancashireCompleted
-
Liverpool John Moores UniversityUnilever R&DCompleted
-
Sheffield Hallam UniversityNewcastle University; Teesside University; Northumbria UniversityCompletedMetabolic SyndromeUnited Kingdom
-
Kowa Research EuropeCompletedMetabolic SyndromeUnited Kingdom
-
University of ReadingCompletedCardiovascular Risk FactorUnited Kingdom
-
University of GlasgowMedical Research CouncilSuspended
-
University of BathCompletedHyperglycemia | Insulin SensitivityUnited Kingdom
-
University Hospitals, LeicesterNational Institute for Health Research, United Kingdom; University of LeicesterCompleted
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsCompletedHyperglycemiaSingapore, United Kingdom, New Zealand
-
University of BedfordshireBritish Nutrition FoundationCompleted
-
University of HertfordshireCompletedDiabetes Mellitus, Type 2 | Sleep Disorder | Pre DiabetesUnited Kingdom
-
City, University of LondonBarts & The London NHS TrustRecruitingVitamin D Status | Hyperglycemia, PostprandialUnited Kingdom
-
University College, LondonPharmacy2UCompleted
-
Derek RichardsUniversity of Dublin, Trinity College; Silver Cloud HealthTerminated
-
University of ChesterRecruitingMenopause | Metabolic Syndrome, Protection AgainstUnited Kingdom
-
iECURE, Inc.RecruitingUrea Cycle Disorders, Inborn | Ornithine Transcarbamylase Deficiency | Ornithine Transcarbamylase Deficiency Disease | Ornithine Carbamoyltransferase Deficiency (Disorder)United Kingdom
-
University of GlasgowNHS Greater Glasgow and Clyde Board HQUnknown
-
University of WarwickUnilever R&D; Technology Strategy Board, United KingdomCompletedGlucose Intolerance | Vasodilation | Aortic StiffnessUnited Kingdom
-
REGENXBIO Inc.Active, not recruitingNeuronal Ceroid Lipofuscinosis Type 2United Kingdom
-
University of ManchesterTerminatedHypoglycemia | DiabetesUnited Kingdom
-
University Hospitals, LeicesterDiabetes UKCompletedPrediabetic StateUnited Kingdom
-
Imperial College LondonCompleted
-
University of EdinburghNHS LothianCompleted
-
University of LeicesterUniversity Hospitals, LeicesterCompleted
-
Imperial College LondonUnknownCardiovascular Diseases | Hyperlipidemias | Adverse EffectsUnited Kingdom
-
University of OxfordBayer; Medical Research Council; Abbott; British Heart Foundation; Solvay Pharmaceuticals and other collaboratorsActive, not recruiting
-
Gilead SciencesCompletedLipodystrophyUnited Kingdom
-
Royal Devon and Exeter NHS Foundation TrustNational Institute for Health Research, United Kingdom; University of Exeter; Diabetes UKActive, not recruitingDiabetes MellitusUnited Kingdom
-
University of DundeeCompleted
-
The Royal Wolverhampton Hospitals NHS TrustCompletedDiabetes | Care DeliveryUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustRecruiting
-
University of AberdeenUnknown
-
Sirtris, a GSK CompanyGlaxoSmithKlineCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United Kingdom
-
University of NottinghamFlorida Department of CitrusCompletedObesity | Insulin ResistanceUnited Kingdom
-
Barnsley HospitalCompleted
-
Loughborough UniversityUnknownGlucose Metabolism Disorders | Insulin Resistance | Type 2 Diabetes | Metabolic DiseaseUnited Kingdom
-
Glyconics LtdCompletedDiabetes Mellitus, Type 2United Kingdom
-
University of AberdeenActive, not recruitingDiabetes Mellitus, Type 2United Kingdom
-
Sirtris, a GSK CompanyGlaxoSmithKlineCompleted
-
Liverpool John Moores UniversityOxford University Hospitals NHS TrustRecruiting
-
University of AberdeenCompleted
-
Nottingham Trent UniversityLoughborough UniversityCompletedObesity | Metabolic SyndromeUnited Kingdom
-
Loughborough UniversityKarolinska Institutet; University of Nottingham; University of Copenhagen; Duke... and other collaboratorsCompletedPhysical Activity | Insulin SensitivityUnited Kingdom
-
Imperial College LondonTerminated
-
Imperial College LondonCompletedDiabetes MellitusUnited Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United Kingdom
-
Imperial College LondonMedical Research Council; CovanceCompletedObesity | Diabetes MellitusUnited Kingdom
-
Novo Nordisk A/SCompleted